APA

Kotake M., Murakami H., Kenmotsu H., Naito T. & Takahashi T. (20180508). High incidence of interstitial lung disease following practical use of osimertinib in patients who had undergone immediate prior nivolumab therapy. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Kotake M, Murakami H, Kenmotsu H, Naito T and Takahashi T. 20180508. High incidence of interstitial lung disease following practical use of osimertinib in patients who had undergone immediate prior nivolumab therapy. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Kotake M., Murakami H., Kenmotsu H., Naito T. and Takahashi T. (20180508). High incidence of interstitial lung disease following practical use of osimertinib in patients who had undergone immediate prior nivolumab therapy. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Kotake M, Murakami H, Kenmotsu H, Naito T and Takahashi T. High incidence of interstitial lung disease following practical use of osimertinib in patients who had undergone immediate prior nivolumab therapy. : Annals of oncology : official journal of the European Society for Medical Oncology. 20180508.